MedTrace Logo

Chemo- and Radiotherapy in Epithelial Vulvar Cancer

NCT01304667 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1618

Last updated 2016-05-10

No results posted yet for this study

Summary

This retrospective, multicenter study is designed to collect tumor characteristics as well as treatment data from patients diagnosed with primary or recurrent squamous cell cancer of the vulva with emphasis on indication and application of radio- and chemotherapy. Application of chemotherapy in primary treatment of vulvar cancer is rare; the study collective is therefore extended to relapsed disease.

Conditions

  • Radio/Chemotherapy in Node Positive Advanced Vulvar Cancer

Sponsors & Collaborators

  • medac GmbH

    collaborator INDUSTRY

  • Philipps University Marburg

    collaborator OTHER

  • AGO Study Group

    lead OTHER

Principal Investigators

  • Sven Mahner, MD PhD · University Medical Center Hamburg-Eppendorf, Department of Gynecology

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01304667 on ClinicalTrials.gov